
|Videos|October 6, 2017
What Are the Results of the REVIVE-2 Trial?
Author(s)Contagion® Editorial Staff
David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.
Advertisement
David Huang, PhD, MD, chief medical officer at Motif Bio, shares the recent results of the REVIVE-2 trial.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Opioid Use Linked to Nearly Double the Risk of C difficile Infection
2
Top Infectious Disease News Stories Week of December 6 - December 12
3
FDA Approves Zoliflodacin for Uncomplicated Urogenital Gonorrhea
4
A Pediatrician’s Perspective on the Latest ACIP Hepatitis B Vaccine Recommendations
5



















































































































































































































































































